By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Association for the Study of Liver Diseases 

1001 North Fairfax Street
Suite 400
Alexandria  Virginia  22314  U.S.A.
Phone: 703-299-9766 Fax: 703-299-9622


SEARCH JOBS



Segment
Research





Company News
Medivir AB (MVRBF) Release: Results From the COSMOS Study With Simeprevir and Sofosbuvir in Cirrhotic and Non-Cirrhotic HCV genotype 1 Patients Presented at American Association for Study of Liver Diseases 11/5/2013 9:42:19 AM
American Association for Study of Liver Diseases Release: First Study of Its Kind Shows That All-oral Treatment Regimen Prevents Hepatitis C Recurrence in Liver Transplant Recipients Who Received Allografts 11/4/2013 10:26:32 AM
Conatus Pharmaceuticals Inc. Presents Data Demonstrating Emricasan's Safety Profile at the American Association for Study of Liver Diseases Liver Meeting 11/4/2013 9:44:42 AM
Medivir AB (MVRBF) Announces That New Simeprevir Data Will be Presented at the American Association for Study of Liver Diseases Meeting 11/4/2013 9:42:13 AM
Salix Pharmaceuticals, Ltd. (SLXP) Outlines Data Presentations at American Association for Study of Liver Diseases Annual Meeting 11/1/2013 7:03:14 AM
Medivir AB (MVIRb.F) Release: Simeprevir Data From COSMOS Study in Hepatitis C Patients Will be Presented as Late-Breaking Presentation at American Association for Study of Liver Diseases 10/7/2013 9:28:31 AM
Medivir AB (MVIRb.F): Simeprevir Data From Cosmos Study in Hepatitis C Patients Will be Presented as Late-Breaking Presentation at American Association for Study of Liver Diseases 10/7/2013 7:49:06 AM
Dr. Graham Foster to Present a Poster on Spring Bank Pharmaceuticals' HCV Drug SB 9200 at the Annual Meeting of the American Association for Study of Liver Diseases 10/7/2013 7:21:10 AM
Simeprevir Data from COSMOS Study in Hepatitis C Patients Accepted as Late-Breaking Presentation at the Annual Meeting of the American Association for Study of Liver Diseases 10/7/2013 7:08:42 AM
Idenix Pharmaceuticals, Inc. (IDIX) Announces Nucleotide Prodrug Program Poster Presentation at the American Association for Study of Liver Diseases Annual Meeting 10/2/2013 9:59:30 AM
1234567
//-->